Variant report
Variant | esv2829877 |
---|---|
Chromosome Location | chr7:83445678-83459908 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs545794172 | chr7:83446437-83446438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs75505909 | chr7:83446448-83446449 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs531423752 | chr7:83446523-83446524 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs543184456 | chr7:83446536-83446537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs574906677 | chr7:83446548-83446549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs142503703 | chr7:83446555-83446556 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs543907663 | chr7:83446567-83446568 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs563395760 | chr7:83446733-83446734 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs547253445 | chr7:83446767-83446768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs148148767 | chr7:83446883-83446884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs116622093 | chr7:83446895-83446896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs373687472 | chr7:83447089-83447090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs551750191 | chr7:83447183-83447184 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs569993165 | chr7:83447189-83447190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs537537227 | chr7:83447191-83447192 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs79975838 | chr7:83447261-83447262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs567835174 | chr7:83447306-83447307 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs535249578 | chr7:83447325-83447326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs141979428 | chr7:83447397-83447398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs578193444 | chr7:83447403-83447404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs189051187 | chr7:83447432-83447433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs557717570 | chr7:83447436-83447437 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs113669990 | chr7:83447450-83447451 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs145990253 | chr7:83447500-83447501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs140668562 | chr7:83447538-83447539 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs561461674 | chr7:83447584-83447585 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs573460026 | chr7:83447587-83447588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs532468260 | chr7:83447589-83447590 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs117178780 | chr7:83447633-83447634 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs559170892 | chr7:83447634-83447635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs533247879 | chr7:83447677-83447678 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs7787602 | chr7:83447703-83447704 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs563679352 | chr7:83447706-83447707 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs528400001 | chr7:83447739-83447740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs181723766 | chr7:83447782-83447783 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs550541046 | chr7:83450400-83450401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs188101119 | chr7:83450454-83450455 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs191595706 | chr7:83450456-83450457 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs184866784 | chr7:83450486-83450487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs73388499 | chr7:83450487-83450488 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs550311451 | chr7:83450489-83450490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs570643777 | chr7:83450500-83450501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs200283925 | chr7:83450538-83450539 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs550361311 | chr7:83450549-83450550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs568975579 | chr7:83450583-83450584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs577001586 | chr7:83450631-83450632 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs536398281 | chr7:83450640-83450641 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs76312273 | chr7:83450644-83450645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs562885324 | chr7:83450712-83450713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs372204365 | chr7:83450774-83450775 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17170743 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Biliary cancer | 19435499 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Cancer | 21183584 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Gastric cancer | 24379144 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lissencephaly | 21572526 | CNVD |
Breast cancer | 17603634 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Williams-beuren syndrome | 16826523 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Wilms tumour | 19318497 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Schizophrenia | 17879154 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 16461572 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 20858243 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21611746 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Schizophrenia | 23813976 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:83446400-83447800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr7:83450400-83451600 | Enhancers | Stomach Mucosa | stomach |
3 | chr7:83450600-83451600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr7:83452800-83454400 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
5 | chr7:83453200-83454600 | Enhancers | Muscle Satellite Cultured Cells | -- |
6 | chr7:83453200-83454600 | Enhancers | HUVEC | blood vessel |
7 | chr7:83453200-83454800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr7:83453400-83453600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr7:83453800-83454200 | Enhancers | NH-A | brain |
10 | chr7:83454600-83456200 | Weak transcription | Muscle Satellite Cultured Cells | -- |
11 | chr7:83454800-83456200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
12 | chr7:83455600-83457400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
13 | chr7:83456200-83457000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
14 | chr7:83456200-83457000 | Enhancers | Muscle Satellite Cultured Cells | -- |
15 | chr7:83456400-83457000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
16 | chr7:83456400-83457000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
17 | chr7:83459000-83459200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
18 | chr7:83459000-83459200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
19 | chr7:83459200-83459400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
20 | chr7:83459200-83460200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
21 | chr7:83459200-83460200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
22 | chr7:83459400-83460200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |